Anti-dementia drugs and hippocampal-dependent memory in rodents
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Abnormalities in hippocampal structure and function are characteristics of early Alzheimer's disease (AD). Behavioral tests measuring hippocampal-dependent memory in rodents are often used to evaluate novel treatments for AD and other dementias. In this study, we review the effects of drugs marketed for the treatment of AD, such as the acetylcholinesterase inhibitors, donepezil, rivastigmine, galantamine and the N-methyl-D-aspartic acid antagonist, memantine, in rodent models of memory impairment. We also briefly describe the effects of novel treatments for cognitive impairment in rodent models of memory impairment, and discuss issues concerning the selection of the animal model and behavioral tests. Suggestions for future research are offered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.
Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.2.274 · Cited by 3,292
The Medial Temporal Lobe Memory System
Squire, L. R., & Zola-Morgan, S. (1991) · Science · doi:10.1126/science.1896849 · Cited by 3,282 · cited 1×
“Impairments in declarative memory functions have also been associated with hippocampal degeneration in a variety of animal species (Squire and Zola-Morgan, 1991).”
BackgroundAlzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 2×
“…mouse develops cognitive impairment in concert with the appearance of amyloid plaques at around 9 months of age (Hsaio et al., 1996), whereas the PDAPP mouse has been reported to show cognitive deficits at 3 months of age, well before the appearance of plaques (8–10 months; Games et al., 1995).”
BackgroundSpontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237 · cited 2×
“These animals show increased atherosclerosis by 3 months (Zhang et al., 1992) and display dendritic alterations by 4 months of age (Masliah et al., 1995; for review of transgenic models see Higgins and Jacobsen, 2003).”
BackgroundMemory deficits associated with senescence: A neurophysiological and behavioral study in the rat.
Barnes, C. A. (1979) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0077579 · Cited by 2,088
Remembrance of places passed: Spatial memory in rats.
Olton, D. S., & Samuelson, R. J. (1976) · Journal of Experimental Psychology: Animal Behavior Processes · doi:10.1037//0097-7403.2.2.97 · Cited by 1,998
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611 · cited 1×
“Moreover, initial attempts to design mouse models with multiple transgenes that more fully express all of the pathological characteristics of AD resulted in mice that are difficult to examine behaviorally owing to confounding gross motor dysfunction (Lewis et al., 2001).”
BackgroundAβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294
McShane, R., Areosa Sastre, A., & Minakaran, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub5 · Cited by 1,155
Joseph, J. A., Shukitt-Hale, B., Denisova, N. A., Bielinski, D., Martin, A., McEwen, J. J., & Bickford, P. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-08114.1999 · Cited by 980 · cited 1×
“also been examined and benefits in water-maze performance have been reported in aged rats given spinach, blueberry or strawberry extracts (Joseph et al., 1999) and in PDAPP transgenic mice given pomegranate juice (Hartman et al.”
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · cited 1×
“The TgCRND8 model displays an extremely high level of Ab42 with visible plaques and cognitive deficits by 3 months of age (Chishti et al., 2001).”
BackgroundParadigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond
Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909 · cited 2×
“Unauthorized reproduction of this article is prohibited. from the receptor and so avoids prolonged NMDA-receptor blockade, which can be detrimental to learning and memory (Lipton, 2006).”
BackgroundA triple dissociation of memory systems: Hippocampus, amygdala, and dorsal striatum.
McDonald, R. J., & White, N. M. (1993) · Behavioral Neuroscience · doi:10.1037/0735-7044.107.1.3 · Cited by 885
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
Dodart, J.-C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) · Nature Neuroscience · doi:10.1038/nn842 · Cited by 858 · cited 1×
“…mouse models of AD, and have reported mostly positive results, especially with early vaccination (Janus et al., 2000; Morgan et al., 2000; Dodart et al., 2002; Kotilinek et al., 2002; Zhang et al., 2003; Sigurdsson et al., 2004; Hartman et al., 2005; Jensen et al., 2005; Asuni et al.,…”
ResultHepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829
Sutherland, R. J., Whishaw, I. Q., & Kolb, B. (1983) · Behavioural Brain Research · doi:10.1016/0166-4328(83)90188-2 · Cited by 592
Fratiglioni, L., Viitanen, M., von Strauss, E., Tontodonati, V., Herlitz, A., & Winblad, B. (1997) · Neurology · doi:10.1212/wnl.48.1.132 · Cited by 556
Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology
Frautschy, S. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00300-1 · Cited by 514
Reversible memory loss in a mouse transgenic model of Alzheimer’s disease
Kotilinek, L. A., Bacskai, B., Westerman, M., Kawarabayashi, T., Younkin, L., Hyman, B. T., Younkin, S., & Ashe, K. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06331.2002 · Cited by 420 · cited 2×
“reported mostly positive results, especially with early vaccination (Janus et al., 2000; Morgan et al., 2000; Dodart et al., 2002; Kotilinek et al., 2002; Zhang et al., 2003; Sigurdsson et al., 2004; Hartman et al., 2005; Jensen et al., 2005; Asuni et al., 2006; Maier et al., 2006; Oddo et al., 2006; Wilcock et al., 2…”
BackgroundResultHippocampal neurons in pre-clinical Alzheimer's disease.
West, M. J., Kawas, C. H., Stewart, W. F., Rudow, G. L., & Troncoso, J. C. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.005 · Cited by 317 · cited 2×
“In AD, the integrity of the hippocampus is compromised by plaques, tangles and, eventually, the loss of synapses and neuron cell bodies (Alzheimer, 1907; Probst et al., 1983; Bussiere et al., 2002; Rekart et al., 2004; West et al., 2004).”
BackgroundWang, L., Swank, J. S., Glick, I. E., Gado, M. H., Miller, M. I., Morris, J. C., & Csernansky, J. G. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00361-6 · Cited by 263 · cited 1×
“Moreover, in-vivo neuroimaging studies demonstrate that decreases in hippocampal volumes are a hallmark of early AD (Wang et al., 2003, 2006).”
BackgroundSelf-citationThe hippocampus and contextual memory retrieval in Pavlovian conditioning
Maren, S., & Holt, W. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00188-6 · Cited by 256
Yamada, K., Tanaka, T., Han, D., Senzaki, K., Kameyama, T., & Nabeshima, T. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00408.x · Cited by 238
Conte, V., Uryu, K., Fujimoto, S., Yao, Y., Rokach, J., Longhi, L., Trojanowski, J. Q., Lee, V. M., McIntosh, T. K., & Praticò, D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02560.x · Cited by 164
Hartman, R. E., Izumi, Y., Bales, K. R., Paul, S. M., Wozniak, D. F., & Holtzman, D. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0664-05.2005 · Cited by 147 · cited 1×
“…results, especially with early vaccination (Janus et al., 2000; Morgan et al., 2000; Dodart et al., 2002; Kotilinek et al., 2002; Zhang et al., 2003; Sigurdsson et al., 2004; Hartman et al., 2005; Jensen et al., 2005; Asuni et al., 2006; Maier et al., 2006; Oddo et al., 2006; Wilcock et al., 2006).”
Transgenic mouse models of Alzheimer's disease: phenotype and application.
(2003) · PubMed · doi:10.1097/01.fbp.0000088420.18414.ff · Cited by 147 · cited 1×
“These animals show increased atherosclerosis by 3 months (Zhang et al., 1992) and display dendritic alterations by 4 months of age (Masliah et al., 1995; for review of transgenic models see Higgins and Jacobsen, 2003).”
Background
Cited by
Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease.
Marucci, G., Buccioni, M., Ben, D. D., Lambertucci, C., Volpini, R., & Amenta, F. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108352 · Cited by 1,147
Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research
Seigers, R., & Fardell, J. E. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.09.006 · Cited by 266
Cholinesterase Inhibitors and Beyond
Pepeu, G., & Giovannini, M. (2009) · Current Alzheimer Research · doi:10.2174/156720509787602861 · Cited by 209
Longevity factor klotho enhances cognition in aged nonhuman primates
Castner, S. A., Gupta, S., Wang, D., Moreno, A. J., Park, C., Chen, C., Poon, Y., Groen, A., Greenberg, K., David, N., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00441-x · Cited by 114
Akinyemi, A. J., Oboh, G., Oyeleye, S. I., & Ogunsuyi, O. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9701-5 · Cited by 82
Metadata
- Authors
- Yuede, C. M., Dong, H., & Csernansky, J. G.
- Venue
- Behavioural Pharmacology
- Published
- 2007-09
- Volume
- 18
- Issue
- 5-6
- Pages
- 347-363
- ISSN
- 0955-8810 (ISSN-L)
- OpenAlex
- W2089351259
- Cited by
- 76
- References
- 27
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.